Celltrion wins patent dispute on Truxima Korea Biomedical Review
Celltrion said Friday that it has won the domestic patent appeal for chronic lymphocytic leukemia (CLL), one of the indications of Biogen’s Rituxan, the original …
Celltrion wins patent dispute on Truxima Korea Biomedical Review
Celltrion said Friday that it has won the domestic patent appeal for chronic lymphocytic leukemia (CLL), one of the indications of Biogen’s Rituxan, the original …